Professor Tom Scriba

Professor Tom Scriba (PhD) is Deputy Director, Immunology at the South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town, where he directs the clinical immunology laboratory. He trained in biological sciences at Stellenbosch University in South Africa and obtained a DPhil (PhD) in T cell Immunology at Oxford University, UK. He returned to South Africa in 2006 to complete a postdoctoral fellowship in paediatric and clinical immunology in TB and vaccinology at the Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town. Dr Scriba’s research focuses on TB vaccine development, immunopathogenesis of M. tuberculosis infection as well as development of biomarkers of key transition points between the clinical stages of M. tuberculosis infection and disease. Dr Scriba’s research is funded by competitive grants from the Bill and Melinda Gates Foundation, European Developing Countries Clinical Trials Partnership, South African Medical Research Foundation, US National Institutes of Health and the European Union.